![](/img/cover-not-exists.png)
THU0215 Long-Term Efficacy and Safety of Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis (SJIA): 5-Year Follow-up of An Open-Label Trial
Ruperto, N., Brunner, H.I., Quartier, P., Constantin, T., Alexeeva, E., Schneider, R., Kone-Paut, I., Schikler, K., Marzan, K., Wulffraat, N., Padeh, S., Chasnyk, V., Wouters, C., Kuemmerle-Deschner,Volume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-eular.3835
Date:
June, 2016
File:
PDF, 155 KB
english, 2016